Researchers form startup to develop peptide drugs for damaged hearts

04/16/2010 | MIT Technology Review

Two U.S. doctors have set up a startup, CardioHeal, to work on peptide treatments that can help repair damaged hearts by stimulating the development of cardiac muscle cells. One of the peptides that is being tested is periostin, which appeared to be effective in improving the condition of pigs that were induced to suffer a heart attack.

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health